Fieldpoint Private Securities’s Ascendis Pharma A/S ASND Stock Holding History

Fieldpoint Private Securities’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Sell	10 -10	-50%	-$942	﹤0.01%	1287
2022 Q1	$2K	Hold	20	–	–	﹤0.01%	1452
2021 Q4	$3K	Hold	20	–	–	﹤0.01%	1378
2021 Q3	$3K	Hold	20	–	–	﹤0.01%	1353
2021 Q2	$3K	Hold	20	–	–	﹤0.01%	1307
2021 Q1	$3K	Hold	20	–	–	﹤0.01%	1290
2020 Q4	$3K	Buy	+20	New	+$3.31K	﹤0.01%	1219

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fieldpoint Private Securities's ASND Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Ascendis Pharma A/S (ASND) stake by 50% in Q2 2022, selling an estimated $942 and leaving 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Fieldpoint Private Securities first reported a position in ASND in Q4 2020 and has held it in 7 quarters since. The position peaked at $3K in Q4 2021. 167 funds tracked by Wall St. Rank hold ASND as of Q2 2022.

Fieldpoint Private Securities held 10 shares of Ascendis Pharma A/S worth $1K as of Q2 2022.
Fieldpoint Private Securities sold 10 Ascendis Pharma A/S shares in Q2 2022, an estimated $942.
Ascendis Pharma A/S made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1287 holding.
Fieldpoint Private Securities first reported a position in Ascendis Pharma A/S in Q4 2020 and has held it in 7 quarters since.
Fieldpoint Private Securities's Ascendis Pharma A/S position peaked at $3K in Q4 2021.
167 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.